PreAxia Health Care Payment Systems

PAXH

Software - Application · Technology

Price

$0.22

+0.00 (+0.00%)

Market Cap

$4.1M

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

PreAxia Health Care Payment Systems Inc. is a small Canadian company that builds software to help manage how healthcare payments are processed. Its main product is a platform that handles health spending accounts and benefits payments, connecting employers, employees, and insurance administrators. The company operates in the healthcare fintech space, helping organizations move away from paper-based claims toward digital payment systems.

PreAxia earns revenue by licensing its software and processing payment transactions through its platform. It operates primarily in Canada and is a very small company with essentially no reported revenue at this stage, which the zero gross margin reflects. The unusually high ROIC figure likely reflects accounting quirks rather than strong business performance, and the company's main risk is that it has not yet demonstrated meaningful commercial traction — making it highly speculative and dependent on securing larger clients or partnerships to grow.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-128.6% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

↓ Declining (-100% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

46.0%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~1 months

$57,330 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

PreAxia Health Care Payment Systems has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

−0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 19.8M (2021) → 19.8M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

—

Data not available

Operating Margin

N/A

—

Data not available

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial